Cargando...
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few fractions with high single-fraction and total...
Guardado en:
| Publicado en: | Clin Transl Radiat Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630187/ https://ncbi.nlm.nih.gov/pubmed/31341985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2019.04.012 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|